APA

Trehu E. G., Mier J. W., Dubois J. S., Sorce D., Klempner M. S., Epstein M., Dinarello C. A., Shapiro L., Kappler K., Ronayne L. & Atkins M. B. (19990209). Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Trehu E G, Mier J W, Dubois J S, Sorce D, Klempner M S, Epstein M, Dinarello C A, Shapiro L, Kappler K, Ronayne L and Atkins M B. 19990209. Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Trehu E. G., Mier J. W., Dubois J. S., Sorce D., Klempner M. S., Epstein M., Dinarello C. A., Shapiro L., Kappler K., Ronayne L. and Atkins M. B. (19990209). Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Trehu E G, Mier J W, Dubois J S, Sorce D, Klempner M S, Epstein M, Dinarello C A, Shapiro L, Kappler K, Ronayne L and Atkins M B. Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera. : Clinical cancer research : an official journal of the American Association for Cancer Research. 19990209.